Cerus Corporation (CERS) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

22/25

Growth 5 Margin 3 Expansion 5 Platform 5 Financial 4

latest quarter score

Earnings Reports

22
CEROS (CERS) Q1 2026: IFC Revenue Surges 90% as Platelet Penetration Expands
May 01, 2026
20
Cirrus (CERS) Q4 2025: EMEA Up 25%, BCA Deal Sets Stage for U.S. Share Gains
March 03, 2026
20
Cirrus (CERS) Q3 2025: IFC Revenue Jumps 70% as Kit Model Accelerates Margin Path
November 07, 2025
22
Cirrus (CERS) Q2 2025: IFC Revenue Surges 180%, Lifting Full-Year Guidance and Platform Momentum
August 06, 2025
21
Cirrus (CERS) Q1 2025: North America Product Revenue Jumps 22% as INT200 Launch Accelerates Global Expansion
July 04, 2025

Browse all companies